Intended for healthcare professionals

News

Appetite suppressant semaglutide is to be made available to treat obesity in England

BMJ 2023; 380 doi: https://doi.org/10.1136/bmj.p556 (Published 08 March 2023) Cite this as: BMJ 2023;380:p556